Skip to main content
anita-grigoriadis2

Professor Anita Grigoriadis

Professor

  • Interim Joint Head of School

Research interests

  • Cancer

Biography

Anita Grigoriadis is a Professor in the School of Cancer and Pharmaceutical Sciences at King’s, the School Lead (International) and Training Lead for the CRUK KHP Centre, and holds a guest lecturership at Birkbeck College, University of London.

Anita started her scientific career at the Research Institute of Molecular Pathology (IMP), University of Vienna (Austria), pursuing a joint PhD between the Ludwig Institute for Cancer Research (LICR), London, and Faculty of Natural Sciences, Salzburg (Austria). Her postdoctoral training on breast cancer genomics started at the LICR, and continued with Professor Alan Ashworth at the Breakthrough Breast Cancer Centre (London), before joining Professor Andrew Tutt at the Breast Cancer NOW Unit at KCL. Since 2013 Anita leads the KCL Cancer Bioinformatics group, which implements analytical approaches to exploit large complex data sets derived from clinically annotated samples and model systems. Her work focuses on the identification of molecular patterns pathognomonic for DNA damage repair defects, plus their immune microenvironment correlates, mainly in triple negative breast cancers, but also pan-cancer. In parallel, Anita leads the newly formed initiative of “CAncer microBiome ImmuNology DAtascience” (CABINDA) at KCL, which investigates histomorphological features reflective of local and systemic immune responses, a patient’s resident microbial communities and how the sum of these individual components influence treatment response and disease progression.

http://cancerbioinformatics.co.uk/

    Research

    cancer bioinformatics
    Cancer Bioinformatics

    The Cancer Bioinformatics group is exploring molecular determinants at the primary tumour site and in the draining lymph nodes, mainly in triple negative breast cancers.

    breast cancer now thumbnail
    Breast Cancer Now Research Unit

    Breast Cancer Now Research Unit

    From Dev Biology to Regen Medicine-hero
    From Developmental Biology to Regenerative Medicine

    Understanding organ development and tissue regeneration provides a framework for elucidating disease mechanisms as well as for developing new therapeutics.

    Spatial Biology hero
    Spatial Biology Network

    The Spatial Biology Network is a cross-faculty research interest group that brings together researchers from various disciplines, ranging from technology development and molecular biology, to bioinformatics and clinical translational research, to explore the complexity of spatial biology.

    News

    Cancer Research UK announce £10.5m boost for clinician scientist training

    Cancer Research UK has announced that organisations in its City of London Centre network are set to receive a multimillion-pound cash injection to train more...

    Medical research scientist

    Seed funding granted to project seeking to boost AI-assisted healthcare

    A King’s-led venture designed to help the UK navigate the path to AI-assisted healthcare has been awarded an initial grant to develop its proposal.

    AI and healthcare

    King's part of £80 million boost in AI research to deliver revolutionary new technologies

    Nine research hubs across the UK will help underpin the country’s commitment to leading AI research, innovation and ethical deployment.

    Hana Chockler UKRI

    Tech event highlights new anti-cancer AI project

    Professor Anita Grigoriadis and members of her lab were invited to a prestigious talk by Cognizant to discuss their Node Code Breakers project and role of AI...

    Cognizant event

    AI model predicts if breast cancer will spread based on lymph node changes

    Artificial intelligence (AI) can predict if an aggressive type of breast cancer will spread based on changes in a patient’s lymph nodes.

    ai-lymph-nodes

    Researchers' new DCIS discovery could help avoid unnecessary breast cancer treatment

    A new study from a team of King’s researchers in the School of Cancer & Pharmaceutical Sciences, led by Professor Elinor Sawyer, has contradicted the view...

    DCIS discovery research 780x440

    AI technology investigated for breast cancer diagnosis

    A new study led by academics at King’s and Guy’s and St Thomas’ NHS Foundation Trust is using historical scans to evaluate how AI-driven diagnostic software...

    AI in healthcare

    Investigating how B cells and antibodies in the immune system respond to breast cancer

    New research aims to understand how B cells react to the presence of breast cancer.

    antibodies

    Events

    21FebFoLSM Inaugural Lectures 2023-24 thumbnail

    Inaugural Lectures: Professors James Galloway & Anita Grigoriadis

    Inspiring talks from two of our new professors about rheumatic diseases epidemiology and breast cancer research

    Please note: this event has passed.

      Research

      cancer bioinformatics
      Cancer Bioinformatics

      The Cancer Bioinformatics group is exploring molecular determinants at the primary tumour site and in the draining lymph nodes, mainly in triple negative breast cancers.

      breast cancer now thumbnail
      Breast Cancer Now Research Unit

      Breast Cancer Now Research Unit

      From Dev Biology to Regen Medicine-hero
      From Developmental Biology to Regenerative Medicine

      Understanding organ development and tissue regeneration provides a framework for elucidating disease mechanisms as well as for developing new therapeutics.

      Spatial Biology hero
      Spatial Biology Network

      The Spatial Biology Network is a cross-faculty research interest group that brings together researchers from various disciplines, ranging from technology development and molecular biology, to bioinformatics and clinical translational research, to explore the complexity of spatial biology.

      News

      Cancer Research UK announce £10.5m boost for clinician scientist training

      Cancer Research UK has announced that organisations in its City of London Centre network are set to receive a multimillion-pound cash injection to train more...

      Medical research scientist

      Seed funding granted to project seeking to boost AI-assisted healthcare

      A King’s-led venture designed to help the UK navigate the path to AI-assisted healthcare has been awarded an initial grant to develop its proposal.

      AI and healthcare

      King's part of £80 million boost in AI research to deliver revolutionary new technologies

      Nine research hubs across the UK will help underpin the country’s commitment to leading AI research, innovation and ethical deployment.

      Hana Chockler UKRI

      Tech event highlights new anti-cancer AI project

      Professor Anita Grigoriadis and members of her lab were invited to a prestigious talk by Cognizant to discuss their Node Code Breakers project and role of AI...

      Cognizant event

      AI model predicts if breast cancer will spread based on lymph node changes

      Artificial intelligence (AI) can predict if an aggressive type of breast cancer will spread based on changes in a patient’s lymph nodes.

      ai-lymph-nodes

      Researchers' new DCIS discovery could help avoid unnecessary breast cancer treatment

      A new study from a team of King’s researchers in the School of Cancer & Pharmaceutical Sciences, led by Professor Elinor Sawyer, has contradicted the view...

      DCIS discovery research 780x440

      AI technology investigated for breast cancer diagnosis

      A new study led by academics at King’s and Guy’s and St Thomas’ NHS Foundation Trust is using historical scans to evaluate how AI-driven diagnostic software...

      AI in healthcare

      Investigating how B cells and antibodies in the immune system respond to breast cancer

      New research aims to understand how B cells react to the presence of breast cancer.

      antibodies

      Events

      21FebFoLSM Inaugural Lectures 2023-24 thumbnail

      Inaugural Lectures: Professors James Galloway & Anita Grigoriadis

      Inspiring talks from two of our new professors about rheumatic diseases epidemiology and breast cancer research

      Please note: this event has passed.